Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Icahn School of Medicine at Mount Sinai-Clinical and Translational Research Center, New York

Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania, Philadelphia

National Institutes of Health/Clinical Center, Bethesda

NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill, Chapel Hill

The Brody School of Medicine at East Carolina University, ECU Adult Specialty Care, Greenville

Rosedale Health & Wellness, Huntersville

Mercer University, Department of Internal Medicine, Macon

Orlando Immunology Center, Orlando

University of Miami Miller School of Medicine Schiff Center for Liver Disease, Miami

Triple O Research Institute, P.A, West Palm Beach

Midway Immunology and Research Center, Ft. Pierce

St. Jude Children's Research Hospital, Memphis

Indiana CTSI Clinical Research Center, Indianapolis

Be Well Medical Center, Berkley

The Crofoot Research, INC., Houston

Central Texas Clinical Research, Austin

AXCES Research Group, Santa Fe

Ruane Clinical Research Group Inc., Los Angeles

Mills Clinical Research, Los Angeles

UCSD AntViral Research Center (AVRC), San Diego

One Community Health, Sacramento

Peter Shalit, M.D., Seattle

Yale University; School of Medicine; AIDS Program, New Haven